Public Market Listing
Live quotes, historical charts, and market capitalization for Kyowa Kirin are available on Yahoo Finance.
View quote & market cap on Yahoo Finance ↗External market data link · No third-party exchange redistribution
Assets
(9 total)
| Target & Modality | |||
|---|---|---|---|
Benralizumab(Fasenra) | Approved | IL-5 receptor alpha · IL-5 receptor alpha (IL-5Rα / CD125); Fc region additionally engages FcγRIIIa on NK cells (ADCC) · IL-5 receptor alpha (IL5RA) on eosinophils/basophilsMonoclonal antibody | Asthma |
brodalumab(Siliq) | Approved | IL-17 receptor AMonoclonal antibody | Psoriasis |
istradefylline(Nourianz) | Approved | adenosine A2ASmall molecule | Parkinson's Disease |
Saxagliptin(Onglyza) | Approved | DPP-4Small molecule | Type 2 Diabetes |
| Approved | NHE3 (sodium/hydrogen exchanger isoform 3)Small molecule | Chronic Kidney DiseaseHyperphosphatemia | |
| Approved | MeninSmall molecule | Acute Myeloid LeukemiaAcute Lymphoblastic Leukemia Relapsed/Refractory Acute Myeloid Leukemia | |
| Phase 1 | EpCAM (CD326) / CD40Multispecific antibody | Non-Small Cell Lung Cancer | |
| Phase 1 | TIM-3 | Acute Myeloid Leukemia | |
| Phase 1 | Undisclosed / early pipelineBiologic (subtype unspecified) | Hypertension |
Discontinued programmes (2)
Development of these assets stopped. Each page states the sourced discontinuation and keeps the trials as evidence history.
Upcoming events
(6 total)
Estimated primary-completion dates from ClinicalTrials.gov and expected earnings reports. These are registry estimates, never confirmed readout dates; they can move as trials progress.
Add these trial readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.
2026 (1)
December 2026 (1)
What to watch
2027 (1)
March 2027 (1)
What to watch
2028 (2)
February 2028 (1)
What to watch
October 2028 (1)
What to watch
2029 (1)
December 2029 (1)
What to watch
2031 (1)
November 2031 (1)
What to watch
Regulatory and conference events
(5)
Filings, regulator decisions, scientific presentations, topline results and licensing deals, each from a dated source. When a source gives only the month, the month is shown.
Recent